<div id="readability-page-1"><div><p>(MT Newswires) -- Centene (CNC) expects all of its business segments to improve in 2026 as the company continues to focus on driving margin across its portfolio after reaffirming its 2025 adjusted earnings per share guidance and providing &#34;positive commentary&#34; in key business lines, Truist Securities said in a Friday note.</p><p> In a recent conference presentation, Centene highlighted the incremental progress in its health benefits ratio for Medicaid, in line with its target of H2 segment ratio improvement. For its Marketplace segment, Centene has refiled rates in states covering about 95% of its membership, a majority of which have already been approved, Truist said.</p><p> For Medicare, preliminary data indicate Stars trends to be in-line with management's expectations, with a possibility for 4-Star plans membership percentage to be &#34;a bit better than expected,&#34; the investment firm added.</p><p> &#34;While the environment continues to carry areas of uncertainty we are encouraged by the company's update,&#34; Truist said.</p><p> Truist raised its price target on Centene to $39 from $35 and reiterated its buy rating.</p><p>Price: 33.99, Change: -0.09, Percent Change: -0.26</p></div></div>

<p>Centene (CNC) anticipates improvements across all business segments by 2026, focusing on margin enhancement. The company reaffirmed its 2025 adjusted earnings per share guidance and received positive feedback on key business lines, according to Truist Securities. Progress in Medicaid's health benefits ratio aligns with targets, and most refiled Marketplace rates have been approved. Medicare's Stars trends meet expectations, with potential for better-than-expected 4-Star plans. Truist raised Centene's price target to $39 from $35, maintaining a buy rating. Current price: $33.99, down 0.26%.</p>

Centene Expects Business Segments to Improve in 2026, Truist Securities Says